Mesenchymal soluble factors confer imatinib drug resistance in chronic myelogenous leukemia cells

Arch Med Sci. 2020 Nov 20;17(1):266-274. doi: 10.5114/aoms.2020.101042. eCollection 2021.

Authors

Ofer Regev^{1

2}, Noa Kidan^{1

3}, Meshel Nicola^{1

2}, Hazem Khamisie¹, Martin Ruthardt⁴, Jamal Mahajna^{1

2}

Affiliations

¹ Department of Nutrition and Natural Products, Migal-Galilee Research Institute, Kiryat Shmona, Israel.
² Department of Biotechnology, Tel Hai College, Kiryat Shmona, Israel.
³ Department of Nutritional Sciences, Tel Hai College, Kiryat Shmona, Israel.
⁴ Department of Hematology, Division of Cancer and Genetics, and Experimental Clinical Medical Center (ECMC), Medical School, Cardiff University, Cardiff, United Kingdom.

No abstract available